The pharmaceutical world is seeing a major shift in diabetes treatment with the introduction of GLP-1 skin applications. These patches offer a seemingly more comfortable alternative to injections of GLP-1 drugs, minimizing the requirement of daily needle pricks. The technology releases the compou